Literature DB >> 11402400

A common ancestral origin of the frequent and widespread 2299delG USH2A mutation.

B Dreyer1, L Tranebjaerg, V Brox, T Rosenberg, C Möller, M Beneyto, M D Weston, W J Kimberling, C W Cremers, X Z Liu, O Nilssen.   

Abstract

Usher syndrome type IIa is an autosomal recessive disorder characterized by mild-to-severe hearing loss and progressive visual loss due to retinitis pigmentosa. The mutation that most commonly causes Usher syndrome type IIa is a 1-bp deletion, described as "2299delG," in the USH2A gene. The mutation has been identified in several patients from northern and southern Europe and from North America, and it has been found in single patients from South America, South Africa, and China. Various studies have reported a range of frequencies (.16-.44) among patients with Usher syndrome, depending on the geographic origin of the patients. The 2299delG mutation may be the one that most frequently causes retinitis pigmentosa in humans. Given the high frequencies and the wide geographic distribution of the mutation, it was of interest to determine whether the mutation resulted from an ancestral mutational event or represented a mutational hotspot in the USH2A gene. Haplotype analysis was performed on DNA samples from 116 unrelated patients with Usher syndrome type IIa; the patients were from 14 countries and represented 148 2299delG alleles. On the basis of six single-nucleotide polymorphisms within the USH2A gene, 12 core haplotypes were observed in a panel of normal chromosomes. However, in our analysis, only one core haplotype was found to be associated with the 2299delG mutation. The data indicate that the widespread geographic distribution of the 2299delG mutation is the result of an ancestral mutation that has spread throughout Europe and into the New World as a result of migration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402400      PMCID: PMC1226039          DOI: 10.1086/321269

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  11 in total

1.  A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation.

Authors:  X Z Liu; C Hope; C Y Liang; J M Zou; L R Xu; T Cole; R F Mueller; S Bundey; W Nance; K P Steel; S D Brown
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss.

Authors:  C Rivolta; E A Sweklo; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  2000-04-20       Impact factor: 11.025

3.  Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families.

Authors:  A Adato; M D Weston; A Berry; W J Kimberling; A Bonne-Tamir
Journal:  Hum Mutat       Date:  2000-04       Impact factor: 4.878

4.  The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations.

Authors:  T Rosenberg; M Haim; A M Hauch; A Parving
Journal:  Clin Genet       Date:  1997-05       Impact factor: 4.438

5.  Mutation of human short tandem repeats.

Authors:  J L Weber; C Wong
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

6.  Usher syndrome: definition and estimate of prevalence from two high-risk populations.

Authors:  J A Boughman; M Vernon; K A Shaver
Journal:  J Chronic Dis       Date:  1983

7.  Prevalence of 2314delG mutation in Spanish patients with Usher syndrome type II (USH2).

Authors:  M M Beneyto; J M Cuevas; J M Millán; C Espinós; E Mateu; P González-Cabo; M Baiget; M Doménech; S Bernal; C Ayuso; B García-Sandoval; M J Trujillo; S Borrego; G Antiñolo; M Carballo; C Nájera
Journal:  Ophthalmic Genet       Date:  2000-06       Impact factor: 1.803

8.  Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa.

Authors:  M D Weston; J D Eudy; S Fujita; S Yao; S Usami; C Cremers; J Greenberg; R Ramesar; A Martini; C Moller; R J Smith; J Sumegi; W J Kimberling; J Greenburg
Journal:  Am J Hum Genet       Date:  2000-03-22       Impact factor: 11.025

9.  Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.

Authors:  J D Eudy; M D Weston; S Yao; D M Hoover; H L Rehm; M Ma-Edmonds; D Yan; I Ahmad; J J Cheng; C Ayuso; C Cremers; S Davenport; C Moller; C B Talmadge; K W Beisel; M Tamayo; C C Morton; A Swaroop; W J Kimberling; J Sumegi
Journal:  Science       Date:  1998-06-12       Impact factor: 47.728

10.  Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium.

Authors:  R J Smith; C I Berlin; J F Hejtmancik; B J Keats; W J Kimberling; R A Lewis; C G Möller; M Z Pelias; L Tranebjaerg
Journal:  Am J Med Genet       Date:  1994-03-01
View more
  27 in total

1.  Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa.

Authors:  Terri L McGee; Babak Jian Seyedahmadi; Meredith O Sweeney; Thaddeus P Dryja; Eliot L Berson
Journal:  J Med Genet       Date:  2010-05-27       Impact factor: 6.318

2.  Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II.

Authors:  E Aller; T Jaijo; M Beneyto; C Nájera; S Oltra; C Ayuso; M Baiget; M Carballo; G Antiñolo; D Valverde; F Moreno; C Vilela; D Collado; H Pérez-Garrigues; A Navea; J M Millán
Journal:  J Med Genet       Date:  2006-11       Impact factor: 6.318

3.  Occurrence, morphology and molecular characterisation of Bopyrid parasite Epipenaeon ingens Nobili, 1906 (Isopoda: Bopyridae).

Authors:  Kanagasabapathy Sivasubramanian; Samuthirapandian Ravichandran; Ganapathy Rameshkumar; Narayanasamy Veerappan
Journal:  J Parasit Dis       Date:  2015-03-21

4.  Detection of mutations in genes associated with hearing loss using a microarray-based approach.

Authors:  Kirby Siemering; Shehnaaz S M Manji; Wendy M Hutchison; Desiree Du Sart; Dean Phelan; Hans-Henrik M Dahl
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

5.  The USH2A c.2299delG mutation: dating its common origin in a Southern European population.

Authors:  Elena Aller; Lise Larrieu; Teresa Jaijo; David Baux; Carmen Espinós; Fernando González-Candelas; Carmen Nájera; Francesc Palau; Mireille Claustres; Anne-Françoise Roux; José M Millán
Journal:  Eur J Hum Genet       Date:  2010-02-10       Impact factor: 4.246

6.  High frequency of the p.R34X mutation in the TMC1 gene associated with nonsyndromic hearing loss is due to founder effects.

Authors:  Mariem Ben Saïd; Mounira Hmani-Aifa; Imen Amar; Shahid Mahmood Baig; Mirna Mustapha; Sedigheh Delmaghani; Abdelaziz Tlili; Abdelmonem Ghorbel; Hammadi Ayadi; Guy Van Camp; Richard J H Smith; Mustafa Tekin; Saber Masmoudi
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

7.  Partial USH2A deletions contribute to Usher syndrome in Denmark.

Authors:  Shzeena Dad; Nanna D Rendtorff; Erik Kann; Anders Albrechtsen; Mana M Mehrjouy; Mads Bak; Niels Tommerup; Lisbeth Tranebjærg; Thomas Rosenberg; Hanne Jensen; Lisbeth B Møller
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

8.  An USH2A founder mutation is the major cause of Usher syndrome type 2 in Canadians of French origin and confirms common roots of Quebecois and Acadians.

Authors:  Inga Ebermann; Robert K Koenekoop; Irma Lopez; Lara Bou-Khzam; Renée Pigeon; Hanno J Bolz
Journal:  Eur J Hum Genet       Date:  2008-07-30       Impact factor: 4.246

9.  Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

Authors:  Yali Xue; Yuan Chen; Qasim Ayub; Ni Huang; Edward V Ball; Matthew Mort; Andrew D Phillips; Katy Shaw; Peter D Stenson; David N Cooper; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

10.  Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene.

Authors:  Michael A Sandberg; Bernard Rosner; Carol Weigel-DiFranco; Terri L McGee; Thaddeus P Dryja; Eliot L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-18       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.